A Swedish cohort study finds that women with longer lifetime estrogen exposure have fewer signs of cerebrovascular pathology later in life. The researchers report that a longer reproductive span is associated with lower odds of having multiple indicators of cerebral small-vessel disease.
Context across the coverage is consistent: both outlets describe the study as being led by researchers at Karolinska Institutet and published in the journal *Neurology*. Medical Xpress emphasizes the role of hormone replacement therapy and differentiates between women with longer reproductive periods who have used or are using such therapy. MedPage Today instead foregrounds the broader idea of “lifetime estrogen exposure” and its association with reduced cerebrovascular pathology, without focusing as specifically on HRT use. Neither source describes additional outcomes beyond brain vessel pathology signs or provides intervention implications.
